Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 9, 2021

View Archived Issues

Proteogenomics approach identifies neoantigens for T-cell immunotherapy in pediatric brain tumors

Attenuated T. gondii injection synergizes with PD-L1 checkpoint blockade against mouse tumors

New model for studying early embryonic development

Shanghai Meiyue Biotech Development describes new coagulation factor XIa inhibitors

New CDK9/cyclin T1 inhibitors identified at Algen Biotechnologies

New ENPP1 inhibitors discovered at Vir Biotechnology

Edgewise Therapeutics patents myosin inhibitors

New Wnt signaling activators identified at Biosplice Therapeutics

EZH2 methylation of p38 linked to breast cancer progression

Dual BRD4 and ULK3 inhibition as novel therapeutic strategy for TNBC

Codiak Biosciences tests exosome-based vaccine platform for SARS-CoV-2

CP-COV03 with dexamethasone produces synergistic effect for severe COVID-19 in hamsters

Discovery of novel o-aminobenzamide derivative with promising activity in models of gastric cancer

Smart Immune collaborates with MSK to expand ProTcell pipeline

New bifunctional piperidinamide derivative as sigma-1 and mu-opioid receptor agonist

Loss of SETDB1-TRIM28 complex boosts the antitumor effects of immune checkpoint blockade

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 18, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 18, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld Science
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Maintenance, man: Lilly’s phase III weight trial hits goals
BioWorld
Eli Lilly and Co. took another step toward adding a way for patients to hang onto their weight loss when the firm disclosed positive top-line data from the phase...